Clinical Trial Update: Study of Paliperidone ER in Adolescents and Young Adults With Autism [Phase 3]

View source ↗

Summary

Phase 3 study of paliperidone ER in adolescents and young adults with autism has completed, with results posted in May 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Invega ER (paliperidone extended-release)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Autism | Phase 3 | Status: COMPLETED | Results posted: 2017-05-16